Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets down on Asian cue
Tue, 4 Feb 09:30 am

The major Asian stock markets have opened the day in the red with Japan (down 3.3%) and Hong Kong (down 2.3%) leading the losses. The Indian share markets have also opened the day on a negative note. Stocks in the realty and software space are leading the losses.

The Sensex todayis down by around 195 points (1.0%), while the NSE-Nifty is down by around 60 points (1.0%). The midcap and smallcap stocks have also opened in the red with the BSE Mid Cap and BSE Small Cap indices trading lower by 0.8% and 0.7% respectively.The rupee is currently trading at Rs 62.71 to the US dollar.

Auto stocks have opened the day on a weak note with TVS Motors and Mahindra & Mahindra Ltd leading the losses. However, Tata Motors Ltd was trading in the green. Hinduja Group flagship firm Ashok Leyland has reported the auto sales volumes for the month of January 2014. The company has reported a decline of 26% YoY for the month with overall sales volumes at 7,847 vehicles as compared to 10,561 vehicles in the corresponding month of last year. The sales of Large Commercial Vehicle (LCV) products in January 2014 registered a fall of 37% to 2,317 units from 3,698 units sold in January 2013. The sales of its overall Medium & Heavy Commercial Vehicle (M&HCV) declined by more than 19% YoY, to 5,530 units from 6,863 units sold in the same month of last year. For the ten months of the financial year 2013-14, the overall sales volumes stood at 71,141 units, down 21% YoY. The sales volumes of LCVs for the same period stood at 24,093 units, down 13% YoY while sales volumes of M&HCVs stood at 47,048 units, down by over 25% YoY.

Indian Pharma stocks have opened the day on a mixed note with Panacea Biotech Ltd and Elder Pharma Ltd leading the losses. However, Divi's Laboratories and J B Chemicals are trading firm. As per a leading financial daily, Lupin Ltd has announced that it will acquire Nanomi BV, an injectable company based in Netherlands. The acquisition aims to expand its business in patented products. As per the management, Nanomi's expertise in nano and micro particles will help Lupin to look at new disease portfolios in the injectable space. Lupin has not disclosed the valuation of the deal. The management expects injectables to be a significant growth area with high technology barriers and limited competition.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets down on Asian cue". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.